Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 3
Submit an article Journal homepage
412
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus

Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand

Kannikar Intawonga Faculty of Public Health, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Suwat Chariyalertsaka Faculty of Public Health, Chiang Mai University, Chiang Mai, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4998-7841View further author information
ORCID Icon,
Kittipan Chalomb Chiang Mai Provincial Health Office, Chiang Mai, ThailandView further author information
,
Thanachol Wonghirundechab Chiang Mai Provincial Health Office, Chiang Mai, ThailandView further author information
,
Woravut Kowatcharakulc Sansai Hospital, Ministry of Public Health, Chiang Mai, ThailandView further author information
,
Aksara Thongprachuma Faculty of Public Health, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Narain Chotirosniramitd Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Kajohnsak Noppakund Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Krit Khwanngernd Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Worachet Teacharake Nakornping Hospital, Ministry of Public Health, Chiang Mai, ThailandView further author information
,
Prapon Piamanante Nakornping Hospital, Ministry of Public Health, Chiang Mai, ThailandView further author information
,
Pannawich Chantaklange Nakornping Hospital, Ministry of Public Health, Chiang Mai, ThailandView further author information
&
Pimpinan Khammawane Nakornping Hospital, Ministry of Public Health, Chiang Mai, ThailandView further author information
 show all
Article: 2291882 | Received 25 Jul 2023, Accepted 04 Dec 2023, Published online: 11 Dec 2023

References

  • Our World in Data. Coronavirus pandemic (COVID-19). [accessed 2023 Nov 16]. https://ourworldindata.org/coronavirus.
  • Doroshenko A. The combined effect of vaccination and nonpharmaceutical public health interventions-ending the COVID-19 pandemic. JAMA Netw Open. 2021;4(6):e2111675. doi:10.1001/jamanetworkopen.2021.11675.
  • Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793–6. doi:10.1016/S1473-3099(21)00143-2.
  • Morbidity and Mortality Weekly Report (MMWR). Interim recommendations from the advisory committee on immunization practices for the use of bivalent booster doses of COVID-19 vaccines — United States; 2022 Oct [accessed 2023 Nov 16]. https://www.cdc.gov/mmwr/volumes/71/wr/mm7145a2.htm.
  • ECDC-EMA statement on booster vaccination with omicron adapted bivalent COVID-19 vaccines. [accessed 2023 Nov 16]. https://www.ema.europa.eu/en/news/ecdc-ema-statement-booster-vaccination-omicron-adapted-bivalent-covid-19-vaccines.
  • WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines [accessed 2023 Nov 16]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccines-SAGE-Roadmap.
  • WHO chief declares end to COVID-19 as a global health emergency [accessed 2023 Nov 16]. https://news.un.org/en/story/2023/05/1136367.
  • Pilz S, Theiler-Schwetz V, Trummer C, Krause R, Ioannidis JPA. SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity. Environ Res. 2022;209:112911. doi:10.1016/j.envres.2022.112911.
  • Nordström P, Ballin M, Nordström A. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Lancet Infect Dis. 2022;22(6):781–90. doi:10.1016/S1473-3099(22)00143-8.
  • Rodda LB, Morawski PA, Pruner KB, Fahning ML, Howard CA, Franko N, Logue J, Eggenberger J, Stokes C, Golez I, et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell. 2022;185(9):1588–601.e14. doi:10.1016/j.cell.2022.03.018.
  • GISAID. nCoV-19 variants dashboard. [accessed 2023 Nov 16]. https://gisaid.org/hcov-19-variants-dashboard/.
  • Intawong K, Olson D, Chariyalertsak S. Application technology to fight the COVID-19 pandemic: lessons learned in Thailand. Biochem Biophys Res Commun. 2021;538:231–237. doi:10.1016/j.bbrc.2021.01.093.
  • Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Ayood P, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, et al. Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand. Int J Inf Dis. 2022;126:31–38. doi:10.1016/j.ijid.2022.11.006.
  • Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, Teacharak W, et al. Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand. PLoS One. 2023;18(5):e0284130. doi:10.1371/journal.pone.0284130.
  • Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Inf. 2021;27(3):315–8. doi:10.1016/j.cmi.2020.11.028.
  • Puenpa J, Rattanakomol P, Saengdao N, Chansaenroj J, Yorsaeng R, Suwannakarn K, Thanasitthichai S, Vongpunsawad S, Poovorawan Y. Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022. Arch Virol. 2023;168(1):26. doi:10.1007/s00705-022-05666-6.
  • Intawong K, Chariyalertsak S, Chalom K, Wonghirundecha T, Kowatcharakul W, Ayood P, Thongprachum A, Chotirosniramit N, Noppakun K, Khwanngern K, et al. Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand. J Microbiol Immunol Infect. 2023 Oct 18;S1684-1182(23):00192–5. doi:10.1016/j.jmii.2023.10.001.
  • Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al-Khatib HA, Smatti MK, Coyle P, Al-Kanaani Z, et al. Effects of previous infection and vaccination on symptomatic omicron infections. N Engl J Med. 2022;387(1):21–34. doi:10.1056/NEJMoa2203965.
  • Carazo S, Skowronski DM, Brisson M, Barkati S, Sauvageau C, Brousseau N, Gilca R, Fafard J, Talbot D, Ouakki M, et al. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. Lancet Inf Dis. 2023;23(1):45–55. doi:10.1016/S1473-3099(22)00578-3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.